disodium cromoglycate + procaterol

Disodium cromoglycate + procaterol is a combination drug consisting of disodium cromoglycate (also known as cromolyn sodium) and procaterol. Disodium cromoglycate is a mast cell stabilizer that inhibits the release of inflammatory mediators from sensitized mast cells, thereby preventing allergic reactions and bronchoconstriction. It is primarily used for the prophylactic treatment of asthma, including exercise-induced asthma, but does not reverse established bronchospasm. Procaterol is a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator by relaxing airway smooth muscle, providing symptomatic relief in conditions such as asthma and chronic obstructive pulmonary disease (COPD). The combination aims to provide both preventive (anti-inflammatory) and immediate bronchodilatory effects for respiratory conditions like asthma[1][2][4].